Clinical Trial Update: Hepatic Artery Infusion With Oxaliplatin [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating hepatic artery infusion with oxaliplatin for colorectal cancer with liver metastases was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer with Liver Metastases

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Colorectal Cancer, Metastasis | Phase 1, Phase 2 | Status: WITHDRAWN